Patent directory · USPTO A61K / A61P
Patents matching “inhibitor”
2,878 pharma patents match "inhibitor" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.
Quick answer
This filtered view shows 2,878 pharmaceutical patents matching "inhibitor" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.
Patent results
-
US 10125131
Selective HDAC3 inhibitors
granted -
US 10125128
GLS1 inhibitors for treating disease
granted -
US 10123984
Neprilysin inhibitors
granted -
US 10125102
Human plasma kallikrein inhibitors
granted -
US 10125134
KRas G12C inhibitors
granted -
US 10117945
mTORC1 inhibitors
granted -
US 10117871
3-hydroxypyrimidine-2,4-dione-5-carboxamides as potent inhibitors of HIV
granted -
US 10111878
N,6-bis(aryl or heteroaryl)-1,3,5-triazine-2,4-diamine compounds as IDH2 mutants inhibitors for the treatment of cancer
granted -
US 10111953
Methods for reducing remnant cholesterol and other lipoprotein fractions by administering an inhibitor of proprotein convertase subtilisin kexin-9 (PCSK9)
granted -
US 10106538
Inhibitors of protein kinases
granted -
US 10106569
Inhibitors of sodium glucose transporter 1 for constipation
granted -
US 10106540
HDAC6 inhibitors and their uses
granted -
US 10100049
JAK kinase inhibitor compounds for treatment of respiratory disease
granted -
US 10098878
HIF-2α inhibitors for treating iron overload disorders
granted -
US 10093684
Substituted imidazo[1,2-a]pyrazines as Syk inhibitors
granted -
US 10093664
Bicyclo[1.1.1]pentane inhibitors of dual leucine zipper (DLK) kinase for the treatment of disease
granted -
US 10093629
Heterocyclic compounds and their use as retinoid-related orphan receptor (ROR) gamma-T inhibitors
granted -
US 10092656
Protease inhibitors having enhanced features
granted -
US 10092583
Imidazopyridines Syk inhibitors
granted -
US 10093668
Substituted aromatic N-heterocyclic compounds as inhibitors of mitogen-activated protein kinase interacting kinase 1 (Mnk1) and 2 (Mnk2)
granted -
US 10093676
Compounds useful as inhibitors of ATR kinase
granted -
US 10093686
Heteroaryl inhibitors of PDE4
granted -
US 10087181
Compound as WNT signaling inhibitor, composition, and use thereof
granted -
US 10085990
Tricyclic compounds as modulators of TNF-α synthesis and as PDE4 inhibitors
granted